Camilla L. Patti

Camilla L. Patti

Auto-generated profile, based on publicly available information

Camilla L. Patti

Departamento de Farmacologia, Universidade Federal de São Paulo, R. Botucatu, 862, Ed. Leal Prado, 1° andar, 04023062 São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2014 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
KGKarina O. Garcia
Karina O. Garcia
FOFelipe L. M. Ornellas
Felipe L. M. Ornellas
PMPriscila K. Matsumoto Martin
Priscila K. Matsumoto Martin
CPCamilla L. Patti
Camilla L. Patti
LMLuiz E. Mello
Luiz E. Mello
BLBeatriz Monteiro Longo
Beatriz Monteiro Longo
Alzheimer´s disease (AD) is clinically characterized by progressive memory loss, behavioural and learning dysfunction and cognitive deficits, such as alterations in social interactions. The major pathological features of AD are the formation of senile plaques and neurofibrillary tangles together with neuronal and vascular damage. The double transgenic mouse model of AD (2xTg-AD) with the APPswe/PS1dE9 mutations shows characteristics that are similar to those observed in AD patients, including social memory impairment, senile plaque formation and vascular deficits. Mesenchymal stem cells (MSCs), when transplanted into the brain, produce positive effects by reducing Aβ deposition in transgenic APP/PS1 mice. Vascular endothelial growth factor (VEGF), exhibits neuroprotective effects against the excitotoxicity implicated in the AD neurodegeneration.The present study investigates the effects of MSCs overexpressing VEGF in hippocampal neovascularization, cognitive dysfunction and senile plaques present in 2xTg-AD transgenic mice. MSC were transfected with uP-VEGF vector, by electroporation and expanded at the 14th passage. 2xTg-AD animals at 6, 9 and 12 months old were transplanted with MSC-VEGF or MSC. The animals were tested for behavioral tasks to access locomotion, novelty exploration, learning and memory, and their brains were analyzed by IHC for vascularization and Aβ plaques. MSC-VEGF treatment favored the neovascularization and diminished senile plaques in hippocampal specific layers. Consequently, the treatment was able to provide behavioral benefits and reduce cognitive deficits by recovering the innate interest to novelty and counteracting memory deficits present in these AD transgenic animals. Therefore, this study has important therapeutic implications for the vascular damage in the neurodegeneration promoted by Alzheimer’s disease.

1 December 2015 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
ABAline R. Borçoi
Aline R. Borçoi
CPCamilla L. Patti
Camilla L. Patti
KZKarina A. Zanin
Karina A. Zanin
André Willian HollaisAndré Willian Hollais
André Willian Hollais
RSRenan Santos-Baldaia
Renan Santos-Baldaia
RFRoberto Frussa-Filho
Roberto Frussa-Filho

1 September 2014 in Neuroscience Letters
Verified
Journal Article
Closed access
LBLaís Berro
Laís Berro
RSR. Santos
R. Santos
André Willian HollaisAndré Willian Hollais
André Willian Hollais
RWR. Wuo-Silva
R. Wuo-Silva
DFD.F. Fukushiro
D.F. Fukushiro
RFR. Frussa-Filho
R. Frussa-Filho

1 April 2012 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
LSLeandro Sanday
Leandro Sanday
KZKarina A. Zanin
Karina A. Zanin
CPCamilla L. Patti
Camilla L. Patti
STSergio Tufik
Sergio Tufik
RFRoberto Frussa-Filho
Roberto Frussa-Filho

18 March 2014 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
PDF file
André Willian HollaisAndré Willian Hollais
André Willian Hollais
CPCamilla L Patti
Camilla L Patti
KZKarina A Zanin
Karina A Zanin
DFDaniela F Fukushiro
Daniela F Fukushiro
LBLaís F Berro
Laís F Berro
RFRoberto Frussa‐Filho
Roberto Frussa‐Filho

1 April 2013 in International Journal of Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
LSLeandro Sanday
Leandro Sanday
CPCamilla L. Patti
Camilla L. Patti
KZKarina A. Zanin
Karina A. Zanin
STSergio Tufik
Sergio Tufik
RFRoberto Frussa-Filho
Roberto Frussa-Filho
In both humans and laboratory animals, the reports of cognitive effects following acute amphetamine (Amph) administration are mixed and depend, for example, on the timing of administration (e.g. before or after task acquisition) and/or on the memory model used. Besides its cognitive effects, Amph produces other important behavioural effects, including alterations in anxiety and general activity, which could modify the subject's internal state, thereby facilitating state-dependent learning. Importantly, state-dependency has been linked to drug dependence in humans. This study evaluates the role of state-dependent learning in Amph-induced memory deficits in mice submitted to a discriminative avoidance task. Mice were given Amph (3 mg/kg) before training and/or before testing in the plus-maze discriminative avoidance task, an animal model that concomitantly evaluates learning, memory, anxiety-like behaviour and general activity. Pre-training Amph administration did not affect the ability to learn the discriminative task, but rather induced anxiogenic-like effects and a marked retention deficit in the test session. This memory impairment was completely absent when animals received Amph before both the training and the test sessions. Amph-induced memory impairment of a discriminative avoidance task is state-dependent, such that a response acquired in the ‘Amph state’ cannot be recalled in the normal state. The involvement of anxiety alterations in this ‘Amph state’ is discussed.